MedPage Today July 12, 2019
Staff

“We’ve waited for decades for this to mature,” said Steven Nissen, MD

In this exclusive MedPage Today video, Steven Nissen, MD, of the Cleveland Clinic, joined us at the recent American College of Cardiology meeting in New Orleans to share his excitement for the potential of continuous glucose monitoring as a method for reducing cardiovascular risk.

Following is a transcript of his remarks:

I’m personally very excited about continuous glucose monitoring, and I’m particularly excited that we’re now seeing the first of a generation of closed-loop systems where there’s actually an adjustment of insulin dosage based upon real-time data with respect to blood glucose. We’ve waited for decades for this to mature and there are several things to think...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, Digital Health, Health System / Hospital, mHealth, Patient / Consumer, Physician, Primary care, Provider, Technology, Wearables
Remote Patient Monitoring Works … What are Payers and Providers Waiting for?
6 pros and cons of virtual nursing
Evolution: Why It’s Time to Look at Digital Health ROI Differently
VA plans to end telehealth copays and fund virtual care access in rural areas
Forward Falls Flat: Healthcare Kiosks Take Another Hit

Share This Article